Bacterial pathogens that have an intracellular life cycle have devised various strategies to subvert specific compartments within host cells and generate niches that ensure their survival, persistence and proliferation. Bacterial entry into eukaryotic cells generally results in bacteria residing within phagosomes, which are intracellular compartments that are dedicated to innate immune detection and degradation of incoming microorganisms, leading to antigen presentation and the development of adaptive immunity. Despite these immune processes, bacteria that are entrapped within phagosomes can survive using various means, including interference with phagosomal maturation to impair fusion with lysosomes, phagosomal disruption and release into the cytosol. Bacteria can also transform the original phagosome into a unique vacuole that acquires functional properties of less bactericidal intracellular compartments; for example, bacteria can modulate the phagosome to interact with the endoplasmic reticulum (ER), which is a large membrane-bound organelle that ensures the biosynthesis of proteins, carbohydrates and lipids, and coordinates their transport along the secretory pathway. The ER delivers these components to their destination compartments, which include the ER itself, the Golgi apparatus, the plasma membrane, the extracellular milieu or the endocytic pathway and autophagic pathway. Given its biosynthetic functions and role along the secretory pathway, the ER is a nutrient-rich intracellular location that is presumably devoid of bactericidal effectors, such as antimicrobial peptides or hydrolytic enzymes, which makes it a suitable niche for the survival, persistence and proliferation of intracellular bacteria.
The ER has crucial roles in cellular homeostasis by controlling the processing and folding of secretory and membrane proteins. When protein folding requirements exceed the ER processing capacity, unfolded proteins accumulate, induce ER stress and trigger the unfolded protein response (UPR), which is an evolutionarily conserved cytoprotective signalling pathway. By inhibiting mRNA translation and by increasing the ER protein folding capacity and ER-associated degradation (ERAD), the UPR can relieve physiological stress on the ER and maintain cellular homeostasis 1 . Failure to restore ER functions results in programmed cell death. In addition, the UPR triggers signal transduction events associated with innate immunity and host defence, linking this physiological response to the detection of intracellular pathogens 2 . Viral infections have long been known to exert stress on the ER and to induce the UPR owing to the demand that these infections place on protein synthesis, and several viruses modulate the UPR to ensure viral protein production, replication and cell survival 3 
Similarly, bacterial proliferation in the ER probably results in ER stress and the induction of the UPR. In agreement with this scenario, recent evidence indicates important roles of the UPR in either promoting or counteracting intracellular proliferation of bacterial pathogens that subvert ER functions and in sensing the effects of bacterial protein delivery into cells. In this Review, we present recent findings that support the UPR as a from IRE1, PERK and ATF6 to assist in refolding proteins within the ER, which correlates with activation of IRE1, PERK and ATF6. Additional signals that emanate from the ER membrane, as well as the cytosol, have also been proposed to activate the UPR 1 . Activation of IRE1, PERK and ATF6 initiates signalling pathways of the UPR to restore homeostasis in the ER, by increased production of chaperones to assist in protein folding, arrested translation of proteins not involved in resolving ER stress, and degradation of terminally misfolded proteins via the ERAD pathway, which coordinates their retrotranslocation through the ER membrane, polyubiquitination and targeting to the proteasome 7 (FIG. 1) .
IRE1 is a multifunctional protein that has kinase and endonuclease activities. The activity of IRE1 is downregulated by binding of BiP [8] [9] [10] and is stimulated by the direct binding of unfolded proteins 2, 6 . Following activation, IRE1 aggregates and autophosphorylates, activating its endonuclease activity 11 . The site-specific endonuclease activity of IRE1 splices the mRNA that encodes the transcription factor X-box-binding protein 1 (XBP1), which results in the translation of an active protein 12 . Production of XBP1 directs the expression of ER-resident molecular chaperones and protein-folding enzymes 13 . In addition to splicing the Xbp1 transcript, IRE1 has a non-specific endonuclease activity that is responsible for rapid degradation of ER membraneassociated mRNA by a process known as regulated IRE1-dependent decay (RIDD) 14, 15 . This response reduces the amount of protein that enters the secretory pathway (FIG. 1) .
Similar to IRE1, PERK is also an ER stress-activated kinase. Following activation by ER stress, PERK homodimerizes and transphosphorylates, which is accompanied by the dissociation of BiP. Activated PERK can then phosphorylate its target, the eukaryotic translation initiation factor-α (eIF2α) 8, 16 . Phosphorylation of eIF2α inhibits synthesis of secretory proteins by inhibiting the assembly of the 80S ribosome, thereby promoting cellular survival during ER stress 17 . At the same time, phosphorylated eIF2α directs translation of the mRNA that encodes the transcription factor ATF4, which induces expression of UPR target genes that are involved in amino acid transport and oxidative stress resistance 17 . Under conditions of prolonged or severe ER stress that the UPR cannot resolve, ATF4 also increases the levels of the transcription factor C/EBP-homologous protein (CHOP), which upregulates genes that are involved in the induction of apoptotic cell death 18 (FIG. 1) .
The third branch of the UPR is initiated by ATF6. Activation of ATF6 results in its translocation to the Golgi apparatus, where it is cleaved by the Golgi-resident proteases site 1 protease (S1P) and S2P 19 . The active amino terminus of ATF6 is translocated to the nucleus, where it binds the ER stress response element upstream of a subset of UPR genes to activate their transcription 20 . The set of ATF6-dependent genes partially overlaps with genes induced by IRE1 and PERK and includes genes with functions in protein folding, protein transport and lipid biosynthesis 20, 21 . In addition, ATF6 can homodimerize with XBP1 to activate genes that are involved in ERAD 22 (FIG. 1) .
Box 1 | Viruses and the unfolded protein response
Viral replication co-opts endoplasmic reticulum (ER) functions to produce viral glycoproteins, which leads to induction of the unfolded protein response (UPR) 109 .
As the downstream effects of UPR activation, including translational attenuation, ER-associated degradation (ERAD) and cell death, can inhibit viral protein production, viruses can manipulate and avoid the UPR to replicate successfully. Although the exact mechanisms that are involved are unknown for most viruses, some of the viral proteins that are involved have been identified; for example, cytomegaloviruses (CMVs) can both induce and modulate the UPR [110] [111] [112] . Induction of the UPR by human CMV (HCMV) protein US11 has been proposed to lead to degradation of major histocompatibility complex (MHC) class I proteins, which is a mechanism that may promote chronic infection 112 . Furthermore, HCMV protein UL50 and its mouse CMV homologue M50 can both downregulate inositol-requiring enzyme 1 (IRE1) to suppress the UPR 111 . Hepatitis C virus also downregulates the IRE1-X-box-binding protein 1 (XBP1) pathway to promote viral replication 113, 114 . Rotavirus can modulate the UPR in two ways: its NSP3 protein blocks translation of UPR target gene transcripts 115 , and cellular infection leads to sequestration of UPR signalling components, such as protein kinase R (PKR)-like ER kinase (PERK) and C/EBP-homologous protein (CHOP), in viral inclusion bodies 116 . As bacteria that replicate within the ER encounter a similar environment, they may share some of these strategies to modulate the UPR; however, additional studies are needed to test this idea. One of the cellular responses downstream of the UPR is the induction of autophagy. Induction of the UPR increases membrane lipid biogenesis and triggers ER expansion via the XBP1 and ATF6 pathways as a means to enhance ER function [23] [24] [25] . ER expansion is regulated by selective autophagy of the ER (so-called reticulophagy or ER-phagy), which promotes the restoration of cellular homeostasis following resolution of ER stress. Although induction of autophagy has been shown to promote the survival of cancer cells 26 , the effect of ER stress-induced autophagy on cell survival seems to be context dependent, as ER stress-induced autophagy led to death of primary cells 27 . Under conditions of strong or sustained ER stress, a failure of the cell to restore homeostasis triggers apoptotic cell death. Although the precise pathways of apoptosis that are induced by ER stress are not known, the PERK-eIF2α-ATF4-CHOP pathway has an important role, by reversing translational arrest, increasing generation of reactive oxygen species and promoting calcium efflux from the ER. Together, these signals lead to cytochrome c release from the mitochondria and loss of membrane potential, which results in apoptosis 18 . Figure 1 | Cellular responses to endoplasmic reticulum stress. In response to an increase in unfolded proteins in the endoplasmic reticulum (ER) lumen, three sensors that are located in the ER membrane -protein kinase R (PKR)-like ER kinase (PERK), inositol-requiring enzyme 1 (IRE1) and activating transcription factor 6 (ATF6) -activate the unfolded protein response (UPR). Under homeostatic conditions, PERK, IRE1 and ATF6 are bound by binding immunoglobulin protein (BiP), which suppresses their activity. In response to ER stress, BiP is recruited away from PERK, IRE1 and ATF6 to promote protein folding, which leads to the activation of these ER stress sensors. PERK is a kinase that auto-activates, dimerizes and phosphorylates its target, eukaryotic translation initiation factor-α (eIF2α). eIF2α prevents the assembly of functional 80S ribosomes, and directs the selective translation of the transcription factor ATF4, which activates transcription of genes involved in the UPR, including the transcription factor C/EBP-homologous protein (CHOP), which is involved in the induction of apoptotic cell death. IRE1 is a bifunctional enzyme that has kinase and endonuclease activity. In response to ER stress, IRE1 autophosphorylates via its kinase domain, which leads to dimerization and activation of its endonuclease activity. The endonuclease function of IRE1 degrades mRNA in the ER (in a process termed regulated IRE1-dependent decay (RIDD)) to decrease protein biosynthesis. IRE1 also splices the transcript that encodes X-box-binding protein 1 (XBP1), which is a second transcription factor that directs the expression of genes involved in restoring cellular homeostasis. ATF6 is a transcription factor that is anchored in the ER membrane, but in response to ER stress, it translocates to the Golgi apparatus, where the transcription factor domain is released from the membrane by sequential action of site 1 protease (S1P) and S2P, which enables its translocation to the nucleus to activate transcription of UPR target genes. ATF4, XBP1 and ATF6 upregulate the transcription of chaperones, which are components of the ER-associated degradation (ERAD) pathway and factors that are involved in autophagy and apoptosis that function to restore cellular homeostasis, or if the disruption to ER function cannot be resolved, initiate programmed cell death. Nature Reviews | Microbiology In addition to autophagy, UPR signalling also interacts with innate immune signalling pathways that lead to inflammation, as activation of IRE1 by ER stress can activate the mitogen-activated protein kinase (MAPK) JNK, which is a key player in the response to inflammatory stimuli 28 (see below). Therefore, although residing in the ER might promote the survival of intracellular bacteria, it is possible that UPR induction might function as an innate immune mechanism against invading bacteria.
The ER: a safe niche for intracellular bacteria Although the ER is thought to provide a hospitable, nutrient-rich organelle devoid of bactericidal functions, only a few bacterial pathogens take advantage of this environment to ensure their intracellular survival and proliferation. The first evidence of bacterial interactions with the ER came from the observations that Legionella pneumophila and Brucella spp. occupy ribosome-studded intracellular vacuoles [29] [30] [31] , which were confirmed to be derived from the ER at both ultrastructural and functional levels [32] [33] [34] [35] [36] . Since these seminal demonstrations,
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, Chlamydia trachomatis 38, 39 and the Chlamydia-related bacterium Simkania negevensis 40 have also been shown to survive and replicate in organelles that closely interact with the ER.
Bacterial trafficking to the ER. The trafficking events leading to the biogenesis of ER-derived organelles containing L. pneumophila and Brucella spp. have been well characterized. Both invoke subversion of early secretory vesicles but involve distinct mechanisms (FIG. 2) . Following phagocytosis by macrophages, plasma membrane-derived Legionella-containing vacuoles (LCVs) avoid phagosomal maturation along the endocytic pathway. Instead, LCVs intercept early secretory vesicles trafficking between the ER and the Golgi apparatus, which cover and subsequently fuse with LCVs, transforming them into vacuoles that have functional features of early secretory compartments 34, 36, 41 . These events eventually enable LCVs to fuse with ER membranes 34, 36, 41 and become replication-permissive organelles that expand following bacterial proliferation (FIG. 2) . Legionella pneumophila recruits early secretory vesicles to its plasma membrane-derived phagosome via delivery of the Dot/Icm type IV secretion system (T4SS) effectors DrrA, LepB and RalF. These effectors modulate activities of the small GTPases RAB1 and ARF1 on the Legionella phagosome (see inset) to bypass the endocytic pathway, and to promote fusion of the Legionella phagosome with the endoplasmic reticulum (ER) and biogenesis of an ER-derived replicative vacuole, termed the Legionella-containing vacuole (LCV). Brucella spp. reside within a vacuole, termed the Brucella-containing vacuole (BCV), which traffics along the endocytic pathway, interacting with early endosomes (EEs), late endosomes (LEs) and lysosomes (Lys). The BCV is then redirected to ER exit sites (ERESs) and fuses with the ER via the action of VirB type IV effector proteins and the small GTPases SAR1 and RAB2. The Brucella effector RicA binds GDP-bound RAB2 in an unknown manner and is required for accumulation of activated, GTP-bound RAB2 on BCVs (see inset). Chlamydia spp. and Simkania negevensis control the traffic and maturation of their vacuole into a large inclusion that physically interacts with the ER at specific contact points (termed synapses). Similarly, Brucella spp. reside within a Brucellacontaining vacuole (BCV) following phagocytic uptake or entry within non-professional phagocytes. However, unlike LCVs, BCVs first undergo maturation along the endocytic pathway to become endosomal BCVs (eBCVs) 42 and partially acquire phagolysosomal properties 33, [43] [44] [45] . This trafficking step is followed by interactions of BCVs with ER exit sites (ERESs) 43, 45 , which are sub-compartments of the ER dedicated to formation and budding of secretory vesicles before their transport to the Golgi apparatus. Sustained BCV-ERES interactions lead to biogenesis of ER-derived vacuoles -named replicative BCVs (rBCVs) -through progressive exchange of endocytic membranes for ER-derived membranes 43 . rBCVs support bacterial replication, which is accompanied by further ER membrane accretion and a dramatic reorganization of the ER into rBCVs when bacterial proliferation is extensive 35 (FIG. 2) .
The obligate intracellular bacteria Chlamydia spp. resides within a large vacuole -the Chlamydia inclusion -which intercepts exocytic traffic between the Golgi apparatus and the plasma membrane to acquire sphingolipids that are necessary for inclusion biogenesis and bacterial growth 46, 47 . Interactions between the Chlamydia inclusion and the ER have recently been revealed in the form of points of contact, known as 'synapses' , between these compartments 38, 39 . These synapses may deliver ER-derived material to the inclusion 39 and are important for inclusion biogenesis and bacterial growth 38, 39 . Similarly, the Chlamydia-like organism S. negevensis generates a large networked vacuole that also harbours contact sites with the ER 40 , which suggests a common strategy of ER subversion among Chlamydiales (FIG. 2) .
Mechanisms of biogenesis of ER-derived bacterial vacuoles.
Although the mechanisms underlying Chlamydia spp. inclusion interactions with the ER remain to be characterized, extensive studies of the biogenesis of L. pneumophila and Brucella abortus ER-derived replicative organelles have provided useful insights into how these pathogens reach the secretory compartment and establish residency in the ER. Both pathogens express a type IV secretion system (T4SS), the Legionella Dot/ Icm and Brucella VirB T4SS
, which directs the intracellular fate of the bacteria by delivering effector proteins into infected cells that modulate host cell pathways. Concomitant with uptake, L. pneumophila delivers the Dot/Icm effector proteins DrrA (also known as SidM), LepB and RalF, which function in a coordinated manner to mediate targeting of LCVs to the ER via the modulation of small GTPases that normally control early secretory vesicle transport (FIG. 2) . DrrA functions as a GDP-GTP exchange factor (GEF) that recruits and activates RAB1 on plasma membrane-derived LCVs to promote recruitment of early secretory vesicles 48, 49 . This process is negatively regulated by LepB, which is a GTPase-activating protein (GAP) that deactivates RAB1 (REF. 50 ). Fusion of secretory vesicles with LCVs involves an unusual DrrA-dependent pairing of plasma membrane and ER-derived vesicle SNARE protein s 51, 52 , which enables direct fusion between a plasma membrane-derived vacuole and early secretory vesicles, thereby mediating LCV bypass of the endocytic pathway. Subsequent to LCV fusion with secretory vesicles, RalF functions as a GEF for ARF1 and promotes its recruitment to LCVs and fusion with ER membranes to generate an ER-derived Legionella spp. replication-permissive organelle 41, 53, 54 . Hence, this pathogen uses an array of effector proteins that co-opt membrane trafficking processes between secretory compartments to promote its residence within an ER-derived organelle.
The role of the Brucella VirB T4SS in conversion of the BCV into an ER-derived organelle has been established on the basis of the inability of virB mutants to undergo sustained interactions with ERESs and to fuse with the ER, which results in failure to replicate and killing within eBCVs 35, 43, 55 . Through acidification and, presumably, through additional intravacuolar cues, eBCVs signal intracellular Brucella spp. to induce expression of the VirB apparatus 44, 45, 56 . Unlike Legionella spp., very little is known about the effector proteins that the Brucella VirB T4SS delivers during infection. The recent identification of 14 Brucella spp. proteins that are delivered into host cells by the VirB apparatus [57] [58] [59] [60] [61] is an important step towards a molecular understanding of VirB functions, but it has yet to yield information about whether these effectors mediate rBCV biogenesis. Several VirB effectors -such as VceC, BspA, BspB, BspC, BspD and BspF-target compartments of the secretory pathway when ectopically expressed in mammalian cells 60, 62 , which suggests that they may modulate specific functions associated with secretory transport. Accordingly, expression of BspA, BspB and BspF impairs secretory trafficking during Brucella spp. infection 60 , which indicates that the bacterium uses type IV secretion to modulate functions of the secretory pathway. Indeed, Brucella spp. require functional ERESs and the small GTPase SAR1 -which controls coatomer protein 122 -are essential to the survival and proliferation of these intracellular pathogens, as they translocate into host cells a range of effector molecules that take control of host functions associated with the biogenesis and trafficking of the bacterial vacuole. As such, they constitute key virulence factors of many pathogenic bacteria.
complex II (COPII)-dependent vesicular budding from ERESs 63,64 -to generate rBCVs 43 . Biogenesis of rBCVs also requires the small GTPase RAB2, to which the Brucella spp. effector RicA binds 58, 65 . RicA specifically interacts with the GDP-bound form of RAB2 but does not show any GEF activity 58 ; therefore, how this interaction modulates RAB2 function remains unclear. Unlike LCVs, ARF1-dependent vesicular trafficking between ERESs and the Golgi apparatus is not required for rBCV biogenesis 43 , which highlights mechanistic differences in how L. pneumophila and Brucella spp. reach the ER.
Bacteria and the UPR Although many of the mechanistic underpinnings of bacterial interactions with the ER remain to be understood, Legionella spp. and Brucella spp. are model organisms to study the bacterial exploitation of this compartment and its consequences. The rare use of the ER by bacterial pathogens for survival and replication raises the question of its permissiveness to infection. Much like many viruses need to modulate the UPR to ensure their replication while overwhelming the biosynthetic capacity of the ER
and protozoan parasites modulate UPR pathways to promote their pathogenesis
, bacteria that proliferate within the ER must be able to deal with the consequences. Although these consequences are still unclear, bacterial replication within the ER elicits the UPR, which could trigger sensing of bacterial pathogenic activities.
Bacterial induction of the UPR.
Several examples support the idea that bacterial infections trigger ER stress and can be sensed via the UPR. The UPR is induced in macrophage-rich granulomatous lesions of mouse lungs that are infected with virulent Mycobacterium tuberculosis, in which apoptotic events are detectable 66 ( The first demonstration of a role of components of the UPR in the Brucella spp. intracellular life cycle was the discovery that IRE1 is necessary for the intracellular growth of B. abortus, using an RNA interference (RNAi) screen for ER-associated factors that are required for bacterial replication in Drosophila melanogaster S2 cells 71 . IRE1 dependency of B. abortus replication, which has been confirmed in mammalian cells, suggests that the UPR is beneficial to the infection. However, depletion of neither ATF6 nor PERK reproduced the effect of IRE1 depletion 71 , which made a role for a canonical UPR activation in B. abortus replication less substantiated.
Direct evidence that B. melitensis infection of mouse macrophages in vitro and in vivo leads to the induction of the three major signalling pathways of the UPR recently established that B. melitensis infection induces physiological ER stress 69 . However, whether bacterial residence and proliferation in the ER is required for induction of the UPR was not addressed in this study, and the fact that a VirB-deficient mutant (which does not reach the ER or replicate) also induced UPR signalling 69 suggests that this response may not be related to bacterial replication in the ER. It will also be important to address whether the three main UPR regulators are required for B. melitensis-induced UPR, or whether only IRE1-dependent signalling contributes to bacterial replication. Counteracting the UPR response with the pharmacological chaperone tauroursodeoxycholic acid (TUDCA) reduces intracellular growth of B. melitensis, which suggests that the induction of the UPR promotes bacterial intracellular growth 69 . However, obtaining more direct evidence will be important to further substantiate this beneficial role of the UPR.
Induction of the UPR by L. monocytogenes occurs via extracellular secretion of its cytolysin listeriolysin O (LLO), which induces all branches of the UPR and leads to ER stress-specific apoptosis 70 (TABLE 1) . The molecular mechanisms by which this toxin functions remain unclear but may be related to the ability of LLO to alter intracellular calcium homeostasis via its pore-forming activity 72 , as calcium imbalance causes ER stress. Nonetheless, evidence that LLO treatment of mammalian cells itself triggers the UPR indicates that the UPR may be induced via external stimuli and may not be restricted to ER-dwelling pathogens.
Bacterial subversion of the UPR.
Although the occurrence of UPR induction following bacterial infection is now supported by several examples, indications that bacteria can modulate this response are less common but are starting to emerge. L. pneumophila recruits components of the ERAD on its vacuole to mediate turnover of bacterial effectors on the vacuolar surface 54 and the proteasome to generate amino acids that are necessary for its intracellular growth 73 , but whether L. pneumophila modulates the UPR is undocumented. By contrast, S. negevensis generates a replicative vacuole that is associated with the induction of ER stress, which the bacterium subsequently downregulates 40 . In addition, S. negevensis prevents the induction of ER stress following treatment
Box 3 | Toxoplasma gondii and the unfolded protein response
The apicomplexan protozoan parasite Toxoplasma gondii occupies a parasitophorous vacuole that forms close interactions with the endoplasmic reticulum (ER) 123, 124 , which suggests that it may influence functions of this compartment. Consistent with this, recent evidence indicates that apoptosis of T. gondii-infected cells involves activation of ER stress pathways 125, 126 , via induction of C/EBP-homologous protein (CHOP)-caspase 12-JNK pathway, which highlights a role for unfolded protein response (UPR) induction during T. gondii infection. Whether the UPR is actively modulated by T. gondii or an indirect response to cellular effects caused by the parasite needs further clarification, but the demonstration that the T. gondii rhoptry protein ROP18 destabilizes the UPR transducer activating transcription factor 6β (ATF6β) to promote its pathogenesis 127 strongly suggests that this pathogen manipulates UPR signalling to its benefit.
with tunicamycin or thapsigargin, as measured by decreased induction of BiP, impaired nuclear translocation of CHOP and reduced activation of eIF2α 40 . Both compounds induce the UPR by perturbing distinct ER functions -tunicamycin inhibits N-linked glycosylation in the ER and affects protein folding, whereas thapsigargin blocks the sarco-ER calcium ATPases (SERCAs), leading to depletion of ER calcium stores -which indicates that S. negevensis probably interferes with common UPR signalling pathways via mechanisms that are yet to be determined. Interestingly, high concentrations of these UPR inducers can overcome S. negevensis-mediated inhibition of the UPR and affect bacterial growth 40 , which suggests that the bacterium actively modulates this response to benefit its intracellular proliferation.
Additional evidence that bacteria modulate the UPR originates from the study of bacterial toxins (TABLE 1) . Similar to the effect of LLO during L. monocytogenes infections 70 , pore-forming toxin (PFT) intoxication of cells leads to induction of the UPR via the p38 MAPK pathway. Pore formation probably triggers p38 MAPK activation, which, in turn, induces the UPR via the IRE1-XBP1 and ATF6 pathways, but not via the PERK pathway, which suggests that the induction of the UPR by PFTs is specific and distinct from that induced by unfolded proteins 74 . UPR induction is protective against PFTs 74 , which indicates that the UPR functions as a defence mechanism against cellular injury that is caused by bacterial toxins. Studies of the mode of action of the AB 5 cytotoxin family subtilase SubAB from Shiga-toxigenic Escherichia coli (STEC) have shown that SubAB specifically cleaves the ER chaperone BiP 75, 76 , owing to unique structural features of its active site. BiP cleavage triggers the IRE1, PERK and ATF6 signalling branches of the UPR to induce transient ER stress and causes cell cycle arrest 75, 77 (FIG. 3) . Cell cycle arrest at the G0 or G1 phase is thought to be a consequence of decreased cyclin D1, which occurs as a result of both inhibition of translation and proteasomal degradation 75 . This exemplifies the ability of pathogenic bacteria to induce the UPR, via delivery of specific proteins that have enzymatic activities directed towards host cell factors.
The observation that induction of the UPR following B. melitensis infection promotes intracellular growth also suggests that the UPR might be targeted by specific bacterial mechanisms to promote survival. Induction of the UPR by B. melitensis depends on the protein TcpB (Toll/interleukin 1 (IL-1)-like receptor (TIR) domaincontaining protein; also called Brucella TIR protein A (BtpA)) 61 , as a mutant lacking tcpB failed to induce the UPR and purified TcpB was sufficient to cause induction of the UPR 69 (TABLE 1) . TcpB has been shown to antagonize Toll-like receptor 2 (TLR2) and TLR4 signalling, via its interaction with myeloid differentiation primary response protein 88 (MYD88) and the TIR domain-containing adapter protein MAL (also known as TIRAP) and inhibition of nuclear factor-κB (NF-κB) activation [78] [79] [80] [81] [82] [83] , and also stabilizes microtubules 80 , which potentially affects ER morphology. It will therefore be interesting to examine whether TcpB-mediated UPR induction results from any of these activities or whether its UPR-inducing effect reflects yet another function. The recent demonstration that TcpB is translocated into host cells by B. abortus, possibly in a VirB-dependent manner 61 , emphasizes the concept that bacterial pathogens may trigger ER stress via the delivery of effectors or toxins, but also raises the question of VirB dependency of UPR induction by Brucella spp.; if TcpB is a VirB effector, one would expect that a VirB-deficient strain also fails to induce the UPR. Hence, further studies are needed to clarify these aspects of induction of the UPR by Brucella spp.. However, induction of the UPR by Brucella spp. may result from more complex interactions with host cells involving several effectors; for example, the VirB T4SS effector VceC induces IRE1-dependent signalling, which leads to induction of the pro-inflammatory cytokines tumour necrosis factor (TNF) and IL-6 (REF. 62 ). VceCmediated stimulation of UPR signalling possibly results from its interactions with, and possible sequestration of, the ER chaperone BiP, which could alter its ability to downregulate IRE1 activation 9, 10 (FIG. 3) . In addition, individual expression of various Brucella spp. effectors (BspC, BspG, BspH, BspI and BspK) also leads to induction of ER stress in HeLa cells, regardless of whether these proteins target the secretory compartment 60 . Interestingly, all of these effectors induced BiP overexpression, but not CHOP overexpression 60 , which suggests that they modulate the IRE1 and ATF6 pathways, but not the PERK pathway, potentially avoiding inhibition of translation, cell cycle arrest and cell death. Hence, our current knowledge of induction of the UPR by Brucella spp. suggests that a multifactorial process enables the bacterium to finely tune this pathway for its own benefit.
The UPR and innate immune signalling
The co-occurrence of ER stress and inflammation in many chronic pathologies, including neurodegenerative diseases, diabetes, obesity and inflammatory bowel disease, suggests that there are interactions between the UPR and inflammation 84 . Indeed, pro-inflammatory cytokines can promote ER stress signalling via oxidative stress, which can alter redox homeostasis in the ER and lead to protein misfolding. In addition, nitric oxide that is produced during inflammation can perturb ER Figure 3 | Induction of the unfolded protein response and inflammation by bacterial virulence factors. Several toxins and type IV secretion system (T4SS) effectors have been implicated in the activation of the unfolded protein response (UPR) and subsequent inflammation. The Brucella abortus T4SS effector VceC targets the endoplasmic reticulum (ER) and binds to binding immunoglobulin protein (BiP), which may inhibit its interaction with protein kinase R (PKR)-like ER kinase (PERK), inositol-requiring enzyme 1 (IRE1) and activating transcription factor 6 (ATF6), thereby promoting the activation of the UPR. The A subunit of the Vibrio cholerae toxin (CTA) and the A subunit of the Shiga toxin (Stx1A) of Shiga toxin-producing Escherichia coli (STEC) bind IRE1 and activate its endonuclease activity. The subtilase cytotoxin (SubAB) of STEC also localizes to the ER and can cleave BiP, which leads to activation of PERK, IRE1 and ATF6. Activation of PERK leads to the phosphorylation of the eukaryotic translation initiation factor 2α (eIF2α) and results in the translation of the transcription factor ATF4, which activates transcription of genes involved in the UPR. Activated IRE1 interacts with the tumour necrosis factor (TNF) receptor-associated factor 2 (TRAF2), which leads to the production of pro-inflammatory cytokines. Activated IRE1 forms a complex with TRAF2, which activates JNK, an upstream signalling molecule that leads to activation of the transcription factor activator protein 1 (AP-1). Activation of nuclear factor-κB (NF-κB) occurs by the recruitment of inhibitor of NF-κB (IκB) kinase (IKK) by TRAF2. IRE1-dependent mRNA decay (RIDD) generates immunostimulatory mRNA fragments that are recognized by the innate immune receptors retinoic acid-inducible protein I (RIG-I) and mitochondrial antiviral signalling protein (MAVS) to activate NF-κB and interferon-regulatory factor 3 (IRF3), which drives expression of pro-inflammatory cytokines and type I interferons. IRE1-mediated activation of X-box-binding protein 1 (XBP1) also promotes the transcription of type I interferons. In the context of cellular intoxication by SubAB, ATF6 also has a role in the activation of NF-κB. ATF6 is a transcription factor that is anchored in the ER membrane, but in response to ER stress, it translocates to the Golgi apparatus, where the transcription factor domain is released from the membrane by sequential action of site 1 protease (S1P) and S2P, which enables its translocation to the nucleus to activate transcription of UPR target genes, but the precise mechanism for ATF6 translocation following STEC infection is not known.
Thioredoxin-interacting protein
(TXNIP). A protein that is induced via protein kinase R (PKR)-like ER kinase (PERK) and inositol-requiring enzyme 1 (IRE1), and that activates inflammatory processes and cell death following unabated endoplasmic reticulum stress.
Hepcidin
A hormone that regulates iron homeostasis in mammals; it has a role in innate immunity as it limits iron availability to bacteria.
function via S-nitrosylation of protein disulphide isomerase (PDI), which inhibits its ability to catalyse disulphide bond formation during protein folding 85 . Furthermore, enhancement of pro-inflammatory cytokine responses by the IRE1-XBP1 pathway in response to TLR2 and TLR4 ligands suggests that there are additional points of intersection between innate immune and ER stress signalling pathways 86 . Conversely, ER stress can activate pro-inflammatory signalling pathways via multiple mechanisms (FIG. 3) .
Overexpression of viral proteins in the ER has long been known to activate the NF-κB and activator protein 1 (AP-1) transcription factors, which induce expression of pro-inflammatory cytokines, such as IL-6 (REFS 87, 88) . One of the pathways that links ER stress to pro-inflammatory cytokine expression is dependent on the kinase activity of IRE1. Activated IRE1 forms a complex with TNF receptor-associated factor 2 (TRAF2), which activates JNK -an upstream signalling molecule that leads to AP-1 activation 28 . In the TNF receptor signalling pathway, activated TRAF2 can also recruit inhibitor of NK-κB (IκB) kinases, leading to their activation, which suggests that recruitment of TRAF2 to the ER membrane by IRE1 activation during the UPR may also promote activation of NF-κB. RIDD can also activate innate immune responses via generation of immunostimulatory mRNA fragments in the cytosol 2, 15 . Similar to fragments that are generated by the antiviral endoribonuclease RNase L 89, 90 , the mRNA fragments generated by RIDD can be detected by the innate immune receptor retinoic acid-inducible protein I (RIG-I) to activate NF-κB and interferonregulatory factor 3 (IRF3), which drives expression of pro-inflammatory cytokines and interferon-β (IFNβ) 2, 89, 91 . The endonuclease activity of IRE1 also activates XBP1, which has been shown to promote transcription of IFNβ via binding of an upstream enhancer, as well as promoting transcription of IL-6 and TNF 86, 92 . In addition to the NF-κB pathway, under conditions of irremediable ER stress, IRE1 can also activate NLRP3 (NOD-, LRR-and pyrin domain-containing 3) inflammasomes in response to redox stress via thioredoxin-interacting protein (TXNIP), which leads to activation of IL-1β and pyroptotic cell death [93] [94] [95] . The PERK-eIF2α-ATF4-CHOP branch of the UPR, which mediates inhibition of translation, interacts with innate immune signalling via activation of NF-κB. As IκB has a short half-life, translational inhibition by this pathway results in a more rapid turnover of IκB and, consequently, activation of NF-κB (FIG. 3) . In the context of cellular intoxication by SubAB, ATF6 also contributes to the activation of NF-κB; however, the precise mechanism for this is unknown 96 . An ATF6-like transcription factor, cyclic AMP response element-binding protein H (CREBH), is activated by ER stress in a similar manner to ATF6, requiring cleavage by S1P and S2P, and has a role in innate immunity by activating hepcidin expression, thereby limiting iron availability to infecting bacteria 97, 98 . It is therefore likely that, depending on the cellular and tissue context of infection, different combinations of these pathways may have a role in the induction of innate immune responses by ER stress.
Studies of viral infection have shown that hijacking of ER functions for production of viral proteins can trigger innate immune responses; however, several viruses can exploit the resulting UPR to promote their replication 3
. Therefore, it is conceivable that subversion of ER function for intracellular replication of bacterial pathogens, such as Legionella spp., Brucella spp., Simkania spp. or Chlamydia spp. may also activate a subset of these surveillance pathways.
Brucella spp. are excellent models to study the intersection of the UPR and innate immunity as they signal only weakly through TLRs, such as TLR2 and TLR4 (REFS 99, 100) . Furthermore, in a mouse model of infection, innate immune responses to Brucella spp. are highly dependent on function of the VirB T4SS 101 . In infected macrophages, the IRE1 branch of the UPR seems to have a key role in the innate immune response to the T4SS, as silencing of IRE1 dampened the production of inflammatory cytokines by infected cells. VceC, which is a T4SS effector protein that localizes to the ER, can activate IRE1-dependent secretion of IL-6 and TNF 62 . As described above, the newly identified T4SS substrates BspC, BspG, BspH, BspI and BspK can also activate the IRE1 pathway in HeLa cells; therefore, it will be interesting to determine whether they synergize with VceC in inducing expression of pro-inflammatory cytokines during infection 60 . Furthermore, it is not known how BtpA, which has recently been shown to induce all three branches of the UPR, influences UPR-induced inflammation 69 . However, induction of UPR-dependent infla mmation during Brucella spp. infection may underlie some similarities in the host response between Brucella spp. and viral infections with regard to their gene expression profiles in vivo 101, 102 . Bacterial toxins can also induce UPR-dependent inflammation (TABLE 1) . Some toxins, such as Shiga toxin and cholera toxin, reach their cytosolic targets via cellular uptake and retrotranslocation to the ER, where they fold before reaching their targets in the cell cytosol. Localization of an enzymatically inactive A subunit of cholera toxin (CTA) to the ER was recently found to activate NF-κB via an IRE1-dependent pathway in intestinal epithelial cells, via binding of unfolded CTA to IRE1 (REF 2) (FIG. 3) . Interestingly, the pathway that leads to NF-κB activation by CTA involves activation of RIDD and sensing of the resulting mRNA fragments via a RIG-I-mitochondrial antiviral signalling protein (MAVS)-dependent pathway. The A subunit of Shiga toxin (Stx1A), which triggers death of intoxicated cells via the UPR 103, 104 , is also able to activate IRE1 and induce NF-κB activation, probably via a similar mechanism to that identified for CTA 2 (FIG. 3) .
Notably, activation of immune cells, particularly T cells, by Shiga toxins has been postulated to play a part in disease progression of haemolytic uremic syndrome caused by STEC, which raises the possibility of a connection between activation of the UPR in intoxicated cells and systemic inflammatory pathology 105 . Interestingly, although cleavage of BiP by SubAB of STEC leads to induction of the three branches of the UPR and, consequently, to a transient activation of NF-κB 96, 106 , pre-stimulation of cells with SubAB at sub-cytotoxic doses was shown to blunt the induction NF-κB activation by heterologous stimuli, such as TLR4 agonists 107 . Therefore, the effect of this toxin on inflammatory responses during an infection may depend on the toxin dose.
The above examples show that eliciting the UPR functions as a pathogen-associated molecular pattern of infection initiates innate immune signalling in response to pathogens that target the ER directly and pathogens that, via the disruption of other cellular processes, perturb ER function. Furthermore, in the context of additional infection-related signals, including TLR ligands 86 and pro-inflammatory cytokines 5 , cellular surveillance of ER function is heightened to generate a more rapid innate immune response to ER stress.
The UPR: friend or foe? Although several bacterial pathogens can induce the UPR during infection, it is not clear in each case whether this response benefits the host or the pathogen. Modulation of ER function by intracellular bacteria can promote infection by providing a replicative niche, but at the same time, the resulting disruption of the secretory pathway can aid the innate immune system in recognizing intracellular infection and in mounting an appropriate defence. However, considering the more rapid evolution of bacterial pathogens compared with their hosts, it is likely that bacteria have evolved to modulate the UPR to their advantage during infection. Given the multitude of virulence genes expressed by bacterial pathogens that replicate in ER-associated cellular compartments, future work is likely to reveal the extent to which viruses and bacteria use shared strategies to exploit this intracellular niche to promote their replication, as well as which novel mechanisms are used by bacteria to manipulate signalling pathways that emanate from the ER. Furthermore, as the UPR has been targeted therapeutically in inflammatory disease and cancer 108 , it would be intriguing to explore this as an adjunct for the treatment of intracellular bacterial infections, such as tuberculosis and brucellosis, which currently require long antibiotic treatment regimens. Given the central importance of the UPR in many disease processes, insights from this area of study are likely to lead to an improved understanding of the links between ER stress signalling pathways and pathology, not only in the context of infection but also of neuro degenerative diseases, diabetes, obesity, inflammatory bowel disease and cancer.
